Word of the Day

Commodity

Even if you don't think you do, you already know plenty about commodities. Want us to prove it? No problem.

What makes oil produced in Saudi Arabia different from oil exported from Nigeria? It's the same thing that makes the corn you ate at last summer¿s barbecue different from the corn used to produce ethanol. Stumped? Well, don't feel bad, it's a trick question. The answer? Absolutely nothing. Corn is corn no matter where it comes from -- just as wheat is wheat and natural gas is -- right! -- natural gas. (Though the quality may differ, the make-up is uniform.)

So, in less elaborate terms, corn and oil (and all other commodities) are homogenous goods that can be processed, resold and more often than not, used as an input to the production of other goods or services. These goods are traded on a commodity exchange, thus setting the price-per-barrel (or other metric unit) used to value them.

Now pay attention, here's a question that indeed does have an answer: What is the difference between a commodity and a stock? While a stock can tank and become worthless, a commodity cannot have its value be wiped to zero. One other difference: Most commodities are traded in futures, meaning traders buy and sell where they think the price of a product will be at a certain point in the future. Stocks trade based on the value of the underlying company at that point in time.

Home / Markets / Industries / Health Care

Thursday, May 29, 2008

Electro-Optical Sciences Announces Participation at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

Email this Story | Respond to Editor | Print

Comtex

IRVINGTON, NY, May 29, 2008 (MARKET WIRE via COMTEX) ----Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind(R), a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma, today announced that Joseph V. Gulfo, MD, MBA, president and chief executive officer, will present at the Needham & Company Biotechnology and Medical Technology Conference taking place at The New York Palace Hotel, June 11 - 12, 2008.

Dr. Gulfo's presentation is scheduled for Wednesday, June 11 at 1:30pm ET. To access the live webcast of this presentation visit www.eosciences.com. A replay of this presentation will be available on the company's website for thirty days following the presentation.

About Electro-Optical Sciences

Electro-Optical Sciences (EOS) is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to help physicians more effectively diagnose melanoma at an early stage. MelaFind(R), the company's flagship product, incorporates advanced imaging technology and algorithms to provide physicians with unique data and an immediate recommendation of whether a suspicious lesion should be biopsied.

Melanoma is the deadliest of skin cancers, responsible for approximately 80% of all skin cancer deaths. Unless melanoma is detected early and excised with proper margins, the patient survival rate is poor, as there is currently no cure for advanced stage melanoma.

For more information on EOS, visit www.eosciences.com.

Safe Harbor

This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved. Actual results may differ materially from our beliefs or expectations due to economic, business, competitive, market and regulatory factors.

 For further information contact: David Carey
   Lazar Partners Ltd. 212-867-1768 Email Contact

SOURCE: Electro-Optical Sciences

http://www2.marketwire.com/mw/emailprcntct?id=7C8566DC433F91A9

Copyright 2008 Market Wire, All rights reserved. **********************************************************************
   As of Sunday, 05-25-2008 23:59, the latest Comtex SmarTrend� Alert, an automated pattern recognition system, indicated an
   UPTREND on 01-29-2008 for MELA @ $5.15. For more information on SmarTrend, contact your market data provider or go to www.mysmartrend.com
   SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright � 2004-2008 Comtex News Network, Inc. All rights
   reserved.